Clinical Research Director Sotagliflozin

IT jobs >> Technology

50,000.00 / Annual

Permanent

Description

Clinical Research Director Sotagliflozin Poste rédigé en anglais : au vu du caractère international du poste, il est indispensable que le/la candidat(e) retenu(e) parle couramment anglais. The Clinical Research Director (CRD), Diabetes Therapeutic Area is responsible for leading the creation and execution of the clinical development strategy for projects in the Diabetes Therapeutic Area (TA). The ultimate goal is to accomplish the expeditious but judicious development of novel compounds with a differentiated product profile that addresses patient’s needs and provides a persuasive value proposition to physicians and payers. Furthermore, the CRD is expected to contribute to the growth of th ...
  • 1
  • $50,000.00 / Annual
  • None
  • None
  • Ex-284134
  • Permanent
  • 0

How to Apply: Please click here to create a free Pure-jobs.com account and post your resume. Only logged in job seekers can apply for a job.

Find us at:

Never provide bank account, credit card details or any other financial information, or make any form of payment, when applying for a job. If you are ever asked to do this by a recruiter on Pure Jobs please click the Report button or contact us with the advertiser's company name and the title of the job vacancy. You should not send any money to anyone. A genuine employer with a job offer would never ask you to do this.

Report this job
x

Report a job

If you're concerned about a job advert, let us know and our quality team will investigate.

Your name(*)
Invalid Input

Your email address(*)
Invalid Input

Please select you reason(*)

Additional information(*)
Invalid Input

Invalid Input

Get new jobs for this search by email.

Also get an email with jobs recommended just for me.

Create Alert

Subscribe to updates from our blog

PLEASE NOTE! WE USE COOKIES AND SIMILAR TECHNOLOGIES FOR THE BEST USER EXPERIENCES

However, by continuing to use the site without changing settings, you are agreeing to our use of cookies.